Zacks wrote yesterday an article about this one, named "Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround" (google it, because I can not share the link and I do not know why lol).

Summary:

Relay Therapeutics (RLAY) has recently faced significant selling pressure, leading to a 27.9% decline over the past four weeks. However, this downturn has pushed the stock into oversold territory, indicating a potential rebound.

Key Factors Suggesting a Rebound:

1. Oversold Condition: The stock's Relative Strength Index (RSI) of 23.42 suggests that the selling pressure may be waning, setting the stage for a potential price reversal.
2. Upward Earnings Revisions: Wall Street analysts have raised their earnings estimates for RLAY, signaling increased optimism about the company's future performance.
3. Strong Zacks Rank: RLAY's Zacks Rank #2 (Buy) indicates strong near-term price appreciation potential.

I am in with around 5.000 shares:

https://preview.redd.it/bgj7hnesma2e1.png?width=1457&format=png&auto=webp&s=c2e5c21a13adcac3103f425a5647ed64a106c50a